EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TERT Promoter C 228 T and C 250 T Hotspot Mutations Are Absent in BRAF V 600 E ‐Positive Langerhans Cell Histiocytosis

Abdou Malik Da Silva iD, Zofia Hélias-Rodzewicz, Irena Ungureanu, Jean-François Emile iD

Cancer Medicine · 2025

DOI: 10.1002/cam4.71115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Abdou Malik Da Silva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Paris-Saclay University, Versailles SQY University, EA4340-BECCOH, Assistance Publique-Hôpitaux de Paris (AP-HP), Ambroise-Paré Hospital, Smart Imagi…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Histiocytosis, Langerhans-Cell, Telomerase, Promoter Regions, Genetic. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PRTK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In various malignancies, the co‐occurrence of BRAF V600E and TERT promoter mutations (C228T and C250T) has been associated with tumor aggressiveness and poor prognosis. However, the presence of these TERT promoter mutations in Langerhans cell histiocytosis (LCH) remains unexplored.

Methods

We investigated the prevalence of TERT promoter C228T and C250T mutations in 40 formalin‐fixed, paraffin‐embedded (FFPE) LCH samples positive for BRAF V600E. A nested PCR approach followed by Sanger sequencing, complemented by NGS, was used for mutation screening.

Results

The variant allele frequency (VAF) of BRAF V600E in the analyzed samples ranged from 0.1% to 33.6%, with a median of 17%, and 33 of 40 successfully amplified LCH samples did not harbor TERT C228T or C250T mutations.

Conclusion

Our findings indicate that LCH BRAF V600E‐positive samples lack the TERT promoter C228T and C250T hotspot mutations. This suggests that TERT promoter mutations may not play a significant role in LCH pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafHistiocytosis, Langerhans-CellTelomerasePromoter Regions, GeneticMutationHumansMaleFemaleAdultMiddle AgedGene FrequencyAdolescentYoung AdultChildAgedDNA Mutational AnalysisChild, Preschool

Stichwörter der Autor:innen

BRAFTERTC228T mutationC250T mutationLangerhans cell histiocytosis

Substanzen

Proto-Oncogene Proteins B-rafTelomeraseTERT protein, humanBRAF protein, human

Autor:innen und Institutionen

  • Paris-Saclay University, Versailles SQY University, EA4340-BECCOH, Assistance Publique-Hôpitaux de Paris (AP-HP), Ambroise-Paré Hospital, Smart Imaging, Service de Pathologie, Boulogne, France.

ORCID-Profile: Abdou Malik Da Silva, Jean-François Emile

Förderung

  • PRTK

Zitieren

APA

Silva, A. M. D., Hélias-Rodzewicz, Z., Ungureanu, I., & Emile, J. F. (2025). TERT Promoter C 228 T and C 250 T Hotspot Mutations Are Absent in BRAF V 600 E ‐Positive Langerhans Cell Histiocytosis. Cancer Medicine. https://doi.org/10.1002/cam4.71115

Vancouver

Silva AMD, Hélias-Rodzewicz Z, Ungureanu I, Emile JF. TERT Promoter C 228 T and C 250 T Hotspot Mutations Are Absent in BRAF V 600 E ‐Positive Langerhans Cell Histiocytosis. Cancer Medicine. 2025. doi:10.1002/cam4.71115

BibTeX
@article{Silva2025,
  author = {Silva, Abdou Malik Da and Hélias-Rodzewicz, Zofia and Ungureanu, Irena and Emile, Jean-François},
  title = {TERT Promoter C 228 T and C 250 T Hotspot Mutations Are Absent in BRAF V 600 E ‐Positive Langerhans Cell Histiocytosis},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71115}
}
Kostenlos starten →